No Data
No Data
Bailong Chuangyuan (605016): 24Q1 creates a new high profit and seizes the opportunity to start production with new production capacity
Event: The company announced its 2023 annual report and 2024 quarterly report. In 2023, the company achieved revenue of 868 million yuan, +20.28% year on year; realized net profit of 193 million yuan, +27.9 million yuan year on year
Bailong Chuangyuan (605016): Steady profit growth in the first quarter of 2023 and 2024, implementation of new production capacity to promote sustainable development
Profitability grew rapidly in 2023, and the company's profit increased in the first quarter of 2024 compared to the same period last year. Bailong Chuangyuan is a leading manufacturer of prebiotics, dietary fiber, and healthy sweetener products in China. The company's main products include oligomers in the prebiotic sector
Bailong Chuangyuan (605016): Production capacity drives steady progress, new production capacity continues to drive performance growth
Event: The company released its 2023 annual report and 2024 quarterly report. In '23, the company achieved revenue of 868 million yuan, an increase of 20.28% over the previous year, and achieved net profit of 193 million yuan to mother, an increase of 28.02% over the previous year
Bailong Chuangyuan (605016): Steady growth in performance, optimistic about the commissioning of new projects
The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved revenue of 868 million yuan, +20.28% year over year, and net profit to mother of 193 million yuan, +27.98% year over year; 2024
Bailong Chuangyuan (605016.SH) announced its 2023 annual results, with net profit of 193 million yuan, an increase of 28.02% year-on-year
Bailong Chuangyuan (605016.SH) released the 2023 annual performance report. During the reporting period, the company achieved an operating income of 8...
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) stock is up by a considerable 7.1% over the past week. Given the company's impressive performance, we decided to study its financial indicators m
No Data